An essential role for tumor necrosis factor in natural killer cell- mediated tumor rejection in the peritoneum

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1611-1619

  Smyth, Mark J ^a   Kelly, Janice M ^a   Baxter, Alan G ^b   Körner, Heinrich ^b,c   Sedgwick, Jonathon D ^b,d  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Natural killer cell; Perforin; Recruitment; Tumor; Tumor necrosis factor

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CYTOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROSTATE CARCINOMA; SPLEEN CELL; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNOLOGY;

EID: 0032476621     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1611     Document Type: Article

References (52)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
2. Whiteside, T.L., and R.B. Herberman. 1994. Human natural killer cells in health and disease. Biology and therapeutic potential. Clin. Immunother. 1:56-66.
3. Holmberg, L.A., K.A. Springer, and K.A. Ault. 1981. Natural killer cell activity in the peritoneal exudate of mice infected with Listeria monocytogenes. J. Immunol. 127:1792-1799.
4. McIntyre, K.W., and R.W. Welsh. 1986. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164:1667-1681.
5. Nemlander, A., E. Saksela, and P. Hayrj. 1983. Are natural killer cells involved in allograft rejection? Eur. J. Immunol. 13: 348-350.
6. Bender, J.R., R. Pardi, M.A. Karasek, and E.G. Engleman. 1987. Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. J. Clin. Invest. 79:1679-1688.
7. Allavena, P., C. Paganin, I. Martin-Padura, G. Peri, M. Gaboli, E. Dejana, P.C. Marchisio, and A. Mantovani. 1991. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173:439-448.
8. Gismondi, A., S. Morrone, M.J. Humphries, M. Piccoli, L. Frati, and A. Santoni. 1991. Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J. Immunol. 146:384-392.
9. Taub, D.D., T.J. Sayers, C.R.D. Carter, and J.R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
10. Maghazachi, A.A. 1991. Tumor necrosis factor-α is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate. J. Leukocyte Biol. 49:302-308.
11. Bianchi, G., M. Sironi, E. Ghibaudi, C. Selvaggini, M. Elices, P. Allavena, and A. Mantovani. 1993. Migration of NK cells across endothelial cell monolayers. J. Immunol. 151:5135-5144.
12. Bottazzi, B., M. Introna, P. Allavena, A. Villa, and A. Mantovani. 1985. In vitro migration of human large granular lymphocytes. J. Immunol. 134:2316-2321.
13. Pohajdak, B., J. Gomez, F.W. Orr, N. Khalil, M. Talgoy, and A.H. Greenberg. 1986. Chemotaxis of large granular lymphocytes. J. Immunol. 136:278-284.
14. Sebok, K., D. Woodside, A. al-Aoukaty, A.D. Ho, S. Gluck, and A.A. Maghazachi. 1993. IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein J. Immunol. 150:1524-1534.
15. Allavena, P., C. Paganin, D. Zhou, G. Bianchi, S. Sozzani, and A. Mantovani. 1994. Interleukin-12 is chemotactic for natural killer cells and stimulates interaction with vascular endothelium. Blood. 84:2261-2268.
16. Whiteside, T.L., and R.B. Herberman. 1992. Extravasation of antitumor effector cells. Invasion Metastasis. 12:128-146.
17. Karre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immunedefence strategy. Nature. 319: 675-678.
18. van den Broek, M.F., D. Kagi, R.M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514-3516.
19. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:31-37.
20. Kagi, D., B. Odermatt, P.S. Ohashi, R.M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143-2152.
21. Kagi, D., B. Ledermann, K. Burki, H. Hengartner, and R.M. Zinkernagel. 1994. CD8+ T cell-mediated protection against an intracellular bacterium by perform. Eur. J. Immunol. 24:3068-3072.
22. Schulz, M., H.J. Schuurman, J. Joergensen, C. Steiner, T. Meerloo, D. Kagi, H. Hengartner, R.M. Zinkernagel, M. Schreier, K. Burki, and B. Ledermann. 1995. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur. J. Immunol. 25:474-480.
23. Oshimi, Y., S. Oda, Y. Honda, S. Nagata, and S. Miyazaki. 1996. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:2909-2915.
24. Magram, J., S.E. Connaughton, W.W. Warrier, D.M. Carvajal, C.Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D.A. Faherty, and M.K. Gately. 1996. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity. 4:471-481.
25. Korner, H., D.S. Riminton, D.H. Strickland, F.A. Lemckert, J.D. Pollard, and J.D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585-1590.
26. Korner, H., M. Cook, D.S. Riminton, F.A. Lemckert, B. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St. Groth, and J.D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600-2609.
27. Baley, P.A., K. Yoshida, W. Qian, I. Sehgal, and T.C. Thompson. 1995. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer. J. Steroid Biochem. Mol. Biol. 52:403-413.
28. Ljunggren, H.G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745-1759.
29. Zhu, X., M. Tommasino, K. Vousden, E. Sadovnikava, R. Rappuoli, L. Crawford, M. Kast, C.J. Melief, P.C. Beverley, and H.J. Stauss. 1995. Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the EV protein of human papilloma virus 16 in H-2d mice. Scand. J. Immunol. 42:557-563.
30. Smyth, M.J., K.Y.T. Thia, and M.H. Kershaw. 1997. Xenogeneic mouse anti-human NK cytotoxicity is mediated via perforin. Xenotransplantation. 4:78-84.
31. Smyth, M.J., V.R. Sutton, M.H. Kershaw, and J.A. Trapani. 1996. Xenospecific cytotoxic T lymphocytes use perforin-and Fas-mediated lytic pathways. Transplantation (Baltimore). 62:1529-1532.
32. van den Broek, M.F., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W.K. Lutz, C.J.M. Melief, R.M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781-1790.
33. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
34. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160:16-19.
35. + T cell development and early IL-4 production in GD1-deficient mice. Immunity. 6:459-467.
36. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:793-802.
37. Pilaro, A.M., D.D. Taub, K.L. McCormick, H.M. Williams, T.J. Sayers, W.E. Fogler, and R.H. Wiltrout. 1994. TNF-α is a principal cytokine involved in recruitment of NK cells to liver parenchyma. J. Immunol. 153:333-342.
38. Pasparikis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
39. Matsumoto, M., Y.X. Fu, H. Molina, and D.D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137-144.
40. Salazar-Mather, T.P., J.S. Orange, and C.A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14.
41. Wiltrout, R.H., B.J. Mathieson, J.E. Talmadge, C.W. Reynolds, S.R. Zhang, R.B. Herberman, and J.R. Ortaldo. 1984. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J. Exp. Med. 160:1431-1449.
42. Sayers, T.J., L.L. Mason, and T.A. Wiltrout. 1990. Trafficking and activation of murine natural killer cells: differing roles for IFN-γ and IL-2. Cell. Immunol. 127:311-326.
43. Riminton, D.S., H. Korner, D.H. Strickland, F.A. Lemckert, J.D. Pollard, and J.D. Sedgwick. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient but not TNF-deficient mice. J. Exp. Med. 187:1517-1528.
44. Carson, W.E., T.A. Fehniger, S. Haldar, K. Eckhert, M.J. Lindemann, C.F. Lai, C.M. Croce, H. Baumann, and M.A. Caligiuri. 1997. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99:937-943.
45. Biron, C.A., G. Sonnenfeld, and R.M. Welsh. 1984. Interferon induces natural killer cell blastogenesis in vivo. J. Leukoc. Biol. 35:31-37.
46. + cells. J. Immunol. 136:3124-3131.
47. Fogler, W.E., K. Volker, K.L. McCormick, M. Watanabe, J.R. Ortaldo, and R.H. Wiltrout. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707-4714.
48. Zhang, B., T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186: 1677-1687.
49. Hedrick, J.A., V. Saylor, D. Figueroa, L. Mizoue, Y. Xu, S. Menon, J. Abrams, T. Handel, and A. Zlotnik. 1997. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J. Immunol. 158:1533-1540.
50. Allavena, P., G. Bianchi, D. Zhou, J. van Damme, P. Jilek, S. Sozzani, and A. Mantovani. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 24:3233-3236.
51. 2+ mobilization, and enzyme release. J. Immunol. 156:322-327.
52. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10-16.